Israel Englander’s Madrigal Pharmaceuticals MDGL Stock Holding History

Israel Englander’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3M	Buy	+36,000	New	+$18.4M	0.01%	1659
2024 Q3	–	Sell	-15,700	Closed	-$4.4M	–	6326
2024 Q2	$4.4M	Buy	15,700 +14,800	+1,644%	+$3.52M	﹤0.01%	2843
2024 Q1	$240K	Sell	900 -600	-40%	-$141K	﹤0.01%	5271
2023 Q4	$347K	Sell	1,500 -8,200	-85%	-$1.43M	﹤0.01%	4883
2023 Q3	$1.42M	Buy	9,700 +7,800	+411%	+$1.47M	﹤0.01%	3896
2023 Q2	$439K	Sell	1,900 -15,700	-89%	-$4.25M	﹤0.01%	4633
2023 Q1	$4.26M	Sell	17,600 -37,700	-68%	-$10.3M	﹤0.01%	2753
2022 Q4	$16.1M	Buy	+55,300	New	+$5.41M	0.01%	1648
2019 Q1	–	Sell	-12,500	Closed	-$1.41M	–	4178
2018 Q4	$1.41M	Hold	12,500	–	–	﹤0.01%	2413
2018 Q3	$2.68M	Buy	+12,500	New	+$3.14M	﹤0.01%	2224

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's MDGL Position: Q2 2026 in Review

Israel Englander increased its Madrigal Pharmaceuticals (MDGL) stake by 99% in Q2 2026, buying an estimated $20.7M and bringing the position to 81,196 shares worth $43.6M. The position accounts for 0.02% of the portfolio, ranked #983.

Israel Englander first reported a position in MDGL in Q2 2013 and has held it in 40 quarters since. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Israel Englander held 81,196 shares of Madrigal Pharmaceuticals worth $43.6M as of Q2 2026.
Israel Englander bought 40,343 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $20.7M.
Madrigal Pharmaceuticals made up 0.02% of Israel Englander's portfolio in Q2 2026, its #983 holding.
Israel Englander first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.